Roche Holding AG
RHO
Company Profile
Business description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact
Grenzacherstrasse 124
Basel4070
CHET: +41 616881111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
103,249
Stocks News & Analysis
stocks
ASX reporting season wrap: BHP, banks, CSL bloodbath and more
A round up of notable stories and reactions as ASX earnings season continues.
stocks
Stock showdown: How do ASX healthcare giants compare on key investing criteria?
Our healthcare analyst Shane Ponraj helps me compare the moatiness and growth prospects of two sector heavyweights.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,234.30 | 55.70 | -0.60% |
CAC 40 | 7,969.69 | 31.40 | 0.40% |
DAX 40 | 24,363.09 | 69.75 | 0.29% |
Dow JONES (US) | 45,631.74 | 846.24 | 1.89% |
FTSE 100 | 9,321.40 | 12.20 | 0.13% |
HKSE | 25,339.14 | 234.53 | 0.93% |
NASDAQ | 21,496.54 | 396.22 | 1.88% |
Nikkei 225 | 42,633.29 | 23.12 | 0.05% |
NZX 50 Index | 13,145.49 | 48.58 | -0.37% |
S&P 500 | 6,466.91 | 96.74 | 1.52% |
S&P/ASX 200 | 8,967.40 | 57.00 | -0.63% |
SSE Composite Index | 3,825.76 | 54.66 | 1.45% |